Added to YB: 2026-01-21
Pitch date: 2026-01-19
TEM [bullish]
Tempus AI, Inc.
-12.25%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$11.6B
Pitch Price
$68.33
Price Target
107.00 (+78%)
Dividend
N/A
EV/EBITDA
-77.06
P/E
-54.93
EV/Sales
11.04
Sector
Life Sciences Tools and Services
Category
growth
The AI Application Layer: The Disruptors - Tempus AI, Inc.
TEM: Disrupting 'Standard of Care' with AI-driven precision medicine. $1.27B revenue, 25% growth guided 3+ years to $2.5B by 2028 in $800B TAM. 126% NRR, 68% data segment growth, 70+ licensing clients. 2026: 24% rev growth, 20,000% EBITDA growth. Fair 10x sales multiple. Base case: 20% margins by 2030 = $19B market cap, 52% upside.
Read full article (1 min)